Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

New therapies aim to improve long-term hair regrowth in alopecia areata by targeting immune responses.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

A cat with a rare pancreatic tumor and diabetes died despite treatment, showing similar symptoms to a human condition.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Combining cell conditioning with mild protease digestion effectively shows versican mRNA in mouse skin sections.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Clonally expanded CD8+ T cells cause alopecia areata.

BST2 is a key marker for hair loss disease alopecia areata.

The 3D skin model mimics pemphigus vulgaris and helps test treatments.

A 24-year-old man developed both alopecia areata universalis and type 1 diabetes at the same time, which is rare.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Two mouse mutations cause similar hair loss despite different skin changes.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.